ArticleThe Journal of urology2020

High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.

Hu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.